The wholesale industry continues to transform, and companies focused on life sciences will face unique challenges in 2015. As specialty drugs gain traction and generics reign, wholesalers will be forced to optimize their product portfolio. Partnering across the value chain will help preserve negotiating power and margins. Serialization regulation has already had an impact, but companies who stay ahead of the curve could experience operational and market share benefits. Additionally, direct-to-consumer sales models could threaten the traditional wholesale industry altogether.

To view the rest of the Wholesale Industry Trends for the Life Sciences Industry, download the PDF below.